RONG-HUATAORONG-HUA TAO11780TAO, RONG-HUAInstructorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson19968579Berkova Z, Tao RH, Samaniego FExpert opinion on investigational drugsMilatuzumab - a promising new immunotherapeutic agent. Expert Opin Investig Drugs. 2010 Jan; 19(1):141-9.Expert Opin Investig Drugs2010-01-01T00:00:002010Milatuzumab - a promising new immunotherapeutic agent.Imaging PhysicsLymphoma-MyelomaMolecular & Cellular OncologyPediatricsRadiation OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorFELIPESAMANIEGOFELIPE SAMANIEGO8869SAMANIEGO, FELIPEAssociate ProfessorJAMES ABANKSONJAMES A BANKSON8928BANKSON, JAMES AAssociate ProfessorSOUMENKHATUASOUMEN KHATUA9716KHATUA, SOUMENAssociate ProfessorARNOLD DELA CRUZPAULINOARNOLD DELA CRUZ PAULINO9923PAULINO, ARNOLD DELA CRUZProfessorVIDYAGOPALAKRISHNANVIDYA GOPALAKRISHNAN9074GOPALAKRISHNAN, VIDYAAssociate Professor25678597Zhu H, Berkova Z, Mathur R, Sehgal L, Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, Rashid A, Samaniego FMolecular cancer research : MCRHuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Mol Cancer Res. 2015 May; 13(5):809-18.Mol Cancer Res2015-02-12T00:00:002015HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.22929310Daniluk U, Kerros C, Tao RH, Wise JF, Ao X, Berkova Z, Samaniego FJournal of experimental & clinical cancer research : CRThe peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells. J Exp Clin Cancer Res. 2012 Aug 28; 31:69.J Exp Clin Cancer Res2012-08-28T00:00:002012The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.25768332Gopalakrishnan V, Tao RH, Dobson T, Brugmann W, Khatua SCNS oncologyMedulloblastoma development: tumor biology informs treatment decisions. CNS Oncol. 2015; 4(2):79-89.CNS Oncol2015-01-01T00:00:002015Medulloblastoma development: tumor biology informs treatment decisions.74Professor54Instructor14Associate Professor47Distinguished Service Professor1515 Holcombe Blvd.Houston77030TX0.425470.00670898104research areas0.698850.033222316coauthor of5.121951.1855259similar to1112selected publicationsAuthorship 863884Molecular Cancer ResearchHuR suppresses fas expression and correlates with patient outcome in liver cancer. Molecular Cancer Research. 13:809-818.HuR suppresses fas expression and correlates with patient outcome in liver cancer23599269Wise JF, Berkova Z, Mathur R, Zhu H, Braun FK, Tao RH, Sabichi AL, Ao X, Maeng H, Samaniego FBloodNucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood. 2013 Jun 06; 121(23):4729-39.Blood2013-04-18T00:00:002013Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.29565247Lee PT, Zirin J, Kanca O, Lin WW, Schulze KL, Li-Kroeger D, Tao R, Devereaux C, Hu Y, Chung V, Fang Y, He Y, Pan H, Ge M, Zuo Z, Housden BE, Mohr SE, Yamamoto S, Levis RW, Spradling AC, Perrimon N, Bellen HJeLifeA gene-specific T2A-GAL4 library for Drosophila. Elife. 2018 03 22; 7.Elife2018-03-22T00:00:002018A gene-specific T2A-GAL4 library for Drosophila.true1ProfessorProfessorAuthorship 8862842Authorship 8866553Authorship 8867246Authorship 8868092Authorship 8882356Authorship 8884527D053222Chemicals & Drugs1011510.932308Fas Ligand ProteinAuthorship 9018842Authorship 9264396Authorship 939859222789015Lu YM, Tao RR, Huang JY, Li LT, Liao MH, Li XM, Fukunaga K, Hong ZH, Han FJournal of neuroinflammationP2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand. J Neuroinflammation. 2012 Jul 12; 9:172.J Neuroinflammation2012-07-12T00:00:002012P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand.28483947Dobson THW, Hatcher RJ, Swaminathan J, Das CM, Shaik S, Tao RH, Milite C, Castellano S, Taylor PH, Sbardella G, Gopalakrishnan VMolecular cancer research : MCRRegulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation. Mol Cancer Res. 2017 08; 15(8):1073-1084.Mol Cancer Res2017-05-08T00:00:002017Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation.30670636Dobson THW, Tao RH, Swaminathan J, Maegawa S, Shaik S, Bravo-Alegria J, Sharma A, Kennis B, Yang Y, Callegari K, Haltom AR, Taylor P, Kogiso M, Qi L, Khatua S, Goldman S, Lulla RR, Fangusaro J, MacDonald TJ, Li XN, Hawkins C, Rajaram V, Gopalakrishnan VScience signalingTranscriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma. Sci Signal. 2019 01 22; 12(565).Sci Signal2019-01-22T00:00:002019Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma.D012097Chemicals & Drugs69016630.553306Repressor ProteinsD002528Disorders1604310.694909Cerebellar NeoplasmsD008527Disorders1705380.66767MedulloblastomaD019014Chemicals & Drugs1031850.89522fas ReceptorDepartment of PediatricsDepartment of Molecular & Human GeneticsMolecular & Human GeneticsPediatrics-OncologyBaylor College of MedicineMURALICHINTAGUMPALAMURALI CHINTAGUMPALA0.000000000000000.000000000000003240CHINTAGUMPALA, MURALIProfessorHUGOBELLENHUGO BELLEN29.71010310000000-95.397396100000003292BELLEN, HUGODistinguished Service ProfessorAuthorship 940700530788681Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan VJournal of neuro-oncologyMonitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol. 2019 May; 142(3):395-407.J Neurooncol2019-02-20T00:00:002019Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.Authorship 945012530968268Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan VJournal of neuro-oncologyCorrection to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol. 2019 May; 142(3):409.J Neurooncol2019-05-01T00:00:002019Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.http://flypush.imgen.bcm.tmc.eduBellen Lab Websitetrue1Distinguished Service ProfessorDistinguished Service Professortrue1ProfessorProfessortrue1InstructorInstructortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor